Skip to content

The effect of s-kitamine on the postoperative delirium in elderly patients

The effect of s-kitamine on the postoperative delirium in elderly patients

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061086
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Dilirum and Postoperative Cognitive Dysfunction

Interventions

Group s-kitamin:s-kitamin
Group sufentanyl:sufentanyl

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged mort than 65 years, no gender limitation; 2. ASA ranged II to III; 3. Patients undergoing selected hip or knee repalcement surgery.

Exclusion criteria

Exclusion criteria: 1. Unable to provide written informed consent; 2. Had Contraindications to esketamine; 3. Had a history of depression or diagnosed with depression; 4. Had dementia or scored 24 or lower on the Mini-mental State Examination (MMSE); 5. Had a score of 15 or higher on the Alcohol Use Disorders Identification Test; 6. Not evaluated the level of anxiety; 7. Not completed the follow-up assessment of delirium.

Design outcomes

Primary

MeasureTime frame
the incidence of postoperative dilirium;

Secondary

MeasureTime frame
the incidence of postoperative cognitive decline;

Countries

China

Contacts

Public ContactJun Ma

The First Affiliated Hospital of University of Science and Technology of China

junma2022@ustc.edu.cn+86 13865991137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026